Sage Therapeutics, Inc.

WELLS FARGO & COMPANY/MN

Report date

6/30/2025

Quarter

2025 Q2

Filed

8/14/2025

Shares

37,033

Value ($000)

338

Weight

0.0%

2019 Q4 - 2025 Q2 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q2	8/14/2025	338	0.0%	37,033	6/30/2025
2025 Q1	5/13/2025	271	0.0%	34,042	3/31/2025
2024 Q4	2/13/2025	179	0.0%	33,051	12/31/2024
2024 Q3	11/13/2024	187	0.0%	25,964	9/30/2024
2024 Q2	8/13/2024	268	0.0%	24,702	6/30/2024
2024 Q1	5/10/2024	325	0.0%	17,322	3/31/2024
2023 Q4	2/9/2024	345	0.0%	15,902	12/31/2023
2023 Q3	11/13/2023	1,813	0.0%	88,109	9/30/2023
2023 Q2	8/15/2023	2,559	0.0%	54,429	6/30/2023
2023 Q1	5/12/2023	2,150	0.0%	51,235	3/31/2023
2022 Q4	2/13/2023	371	0.0%	9,723	12/31/2022
2022 Q3	11/14/2022	485	0.0%	12,387	9/30/2022
2022 Q2	8/12/2022	83	0.0%	2,572	6/30/2022
2022 Q1	5/16/2022	52	0.0%	1,552	3/31/2022
2021 Q4	2/14/2022	53	0.0%	1,246	12/31/2021
2021 Q3	11/15/2021	3,294	0.0%	74,343	9/30/2021
2021 Q2	8/16/2021	7,063	0.0%	124,336	6/30/2021
2021 Q1	5/13/2021	7,748	0.0%	103,516	3/31/2021
2020 Q4	2/9/2021	9,148	0.0%	105,757	12/31/2020
2020 Q3	11/5/2020	8,806	0.0%	144,065	9/30/2020
2020 Q2	8/13/2020	5,384	0.0%	129,476	6/30/2020
2020 Q1	5/14/2020	3,316	0.0%	115,462	3/31/2020
2019 Q4	2/14/2020	5,663	0.0%	78,450	12/31/2019